News & Updates

Prednisone, but not biologic use, tied to increased COVID-19 severity

28 Jul 2021 by

Use of prednisone prior to SARS-CoV-2 diagnosis may be linked to a higher risk of severe COVID-19 outcomes such as hospitalization, intensive care unit (ICU) admission, and death, according to a retrospective community-based study.

Prednisone, but not biologic use, tied to increased COVID-19 severity

28 Jul 2021

Febuxostat does not increase risks of CVD events, death

28 Jul 2021

Use of febuxostat is safe and does not lead to a heightened risk of all-cause mortality, death from cardiovascular events (CVD), or CVD events, reports a recent study, adding that the medication is safe for the treatment of gout.

Febuxostat does not increase risks of CVD events, death

28 Jul 2021

Polyphenols show therapeutic potential in osteoarthritis

28 Jul 2021

Polyphenols may offer a promising alternative treatment for osteoarthritis, with the results of a meta-analysis showing that its use lessens symptoms while reducing safety risks.

Polyphenols show therapeutic potential in osteoarthritis

28 Jul 2021

Bimekizumab triumphs over secukinumab in improving skin clearance in plaque psoriasis

13 Jul 2021 by

Bimekizumab appeared to be more effective than secukinumab in improving skin clearance in patients with moderate-to-severe plaque psoriasis, according to the multinational, phase IIIb BE RADIANT trial presented at AAD 2021.

Bimekizumab triumphs over secukinumab in improving skin clearance in plaque psoriasis

13 Jul 2021

People with psoriatic arthritis at greater risk of developing osteoarthritis

03 Jul 2021

Patients with psoriatic arthritis (PsA) appear to have a higher risk of osteoarthritis (OA) than those with psoriasis alone and those in the general population, reports a study.

People with psoriatic arthritis at greater risk of developing osteoarthritis

03 Jul 2021

Fatigue tied to more comorbidities, pain, TNFi treatment in PsA patients

02 Jul 2021

Fatigue continues to be a leading symptom following treatment with tumour necrosis factor inhibitor (TNFi), a recent study has found. It has also been linked to pain, higher baseline disease activity, and Health Assessment Questionnaire (HAQ); more comorbidities, and a higher risk of TNFi treatment discontinuation in a cohort of Danish patients with psoriatic arthritis (PsA).

Fatigue tied to more comorbidities, pain, TNFi treatment in PsA patients

02 Jul 2021

Childhood-onset SLE a burden on academic achievement, employment in adult life

02 Jul 2021

Childhood-onset systemic lupus erythematosus (cSLE) has been shown to have a considerable impact on academic achievements and employment despite patients adjusting their educational and vocational choices, reveals a study.

Childhood-onset SLE a burden on academic achievement, employment in adult life

02 Jul 2021

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

01 Jul 2021

Patients with asymptomatic uricaemia or gout may do well to keep their serum uric acid levels below 6.0 mg/dL, which has been shown to minimize the occurrences of gout flare in a recent study.

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

01 Jul 2021

Plant-based protein diet lowers serum urate in gout patients

29 Jun 2021

A Dietary Approaches to Stop Hypertension (DASH)-style diet with an emphasis on plant-based protein reduces serum urate relative to that rich in carbohydrates or unsaturated fat, reports a recent study.

Plant-based protein diet lowers serum urate in gout patients

29 Jun 2021

Gout, hyperuricaemia do not influence dementia risk

28 Jun 2021 by

There is no clear evidence that gout and hyperuricaemia contribute to a heightened risk of dementia, although both conditions may be protective against Alzheimer’s disease, as shown in a study.

Gout, hyperuricaemia do not influence dementia risk

28 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Prednisone, but not biologic use, tied to increased COVID-19 severity

Prednisone, but not biologic use, tied to increased COVID-19 severity

Febuxostat does not increase risks of CVD events, death

Febuxostat does not increase risks of CVD events, death

Polyphenols show therapeutic potential in osteoarthritis

Polyphenols show therapeutic potential in osteoarthritis

Bimekizumab triumphs over secukinumab in improving skin clearance in plaque psoriasis

Bimekizumab triumphs over secukinumab in improving skin clearance in plaque psoriasis

People with psoriatic arthritis at greater risk of developing osteoarthritis

People with psoriatic arthritis at greater risk of developing osteoarthritis

Fatigue tied to more comorbidities, pain, TNFi treatment in PsA patients

Fatigue tied to more comorbidities, pain, TNFi treatment in PsA patients

Childhood-onset SLE a burden on academic achievement, employment in adult life

Childhood-onset SLE a burden on academic achievement, employment in adult life

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

Plant-based protein diet lowers serum urate in gout patients

Plant-based protein diet lowers serum urate in gout patients

Gout, hyperuricaemia do not influence dementia risk

Gout, hyperuricaemia do not influence dementia risk